These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents. Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269 [TBL] [Abstract][Full Text] [Related]
69. An oral SARS-CoV-2 M Owen DR; Allerton CMN; Anderson AS; Aschenbrenner L; Avery M; Berritt S; Boras B; Cardin RD; Carlo A; Coffman KJ; Dantonio A; Di L; Eng H; Ferre R; Gajiwala KS; Gibson SA; Greasley SE; Hurst BL; Kadar EP; Kalgutkar AS; Lee JC; Lee J; Liu W; Mason SW; Noell S; Novak JJ; Obach RS; Ogilvie K; Patel NC; Pettersson M; Rai DK; Reese MR; Sammons MF; Sathish JG; Singh RSP; Steppan CM; Stewart AE; Tuttle JB; Updyke L; Verhoest PR; Wei L; Yang Q; Zhu Y Science; 2021 Dec; 374(6575):1586-1593. PubMed ID: 34726479 [TBL] [Abstract][Full Text] [Related]
70. Bioactivity of Rizzo R; Pistillo M; Germinara GS; Lo Verde G; Sinacori M; Maggi F; Petrelli R; Spinozzi E; Cappellacci L; Zeni V; Canale A; Benelli G Insects; 2021 Sep; 12(10):. PubMed ID: 34680649 [TBL] [Abstract][Full Text] [Related]
71. A bioluminescent and homogeneous SARS-CoV-2 spike RBD and hACE2 interaction assay for antiviral screening and monitoring patient neutralizing antibody levels. Alves J; Engel L; de Vasconcelos Cabral R; Rodrigues EL; de Jesus Ribeiro L; Higa LM; da Costa Ferreira Júnior O; Castiñeiras TMPP; de Carvalho Leitão I; Tanuri A; Goueli SA; Zegzouti H Sci Rep; 2021 Sep; 11(1):18428. PubMed ID: 34531417 [TBL] [Abstract][Full Text] [Related]
72. Lethal and behavioural effects of a green insecticide against an invasive polyphagous fruit fly pest and its safety to mammals. Benelli G; Ceccarelli C; Zeni V; Rizzo R; Lo Verde G; Sinacori M; Boukouvala MC; Kavallieratos NG; Ubaldi M; Tomassoni D; Benvenuti F; Roy P; Petrelli R; Cappellacci L; Spinozzi E; Maggi F; Canale A Chemosphere; 2022 Jan; 287(Pt 2):132089. PubMed ID: 34509765 [TBL] [Abstract][Full Text] [Related]
73. Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2. Dittmar M; Lee JS; Whig K; Segrist E; Li M; Kamalia B; Castellana L; Ayyanathan K; Cardenas-Diaz FL; Morrisey EE; Truitt R; Yang W; Jurado K; Samby K; Ramage H; Schultz DC; Cherry S Cell Rep; 2021 Apr; 35(1):108959. PubMed ID: 33811811 [TBL] [Abstract][Full Text] [Related]
74. Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection. Jan JT; Cheng TR; Juang YP; Ma HH; Wu YT; Yang WB; Cheng CW; Chen X; Chou TH; Shie JJ; Cheng WC; Chein RJ; Mao SS; Liang PH; Ma C; Hung SC; Wong CH Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33452205 [TBL] [Abstract][Full Text] [Related]
75. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. Baden LR; El Sahly HM; Essink B; Kotloff K; Frey S; Novak R; Diemert D; Spector SA; Rouphael N; Creech CB; McGettigan J; Khetan S; Segall N; Solis J; Brosz A; Fierro C; Schwartz H; Neuzil K; Corey L; Gilbert P; Janes H; Follmann D; Marovich M; Mascola J; Polakowski L; Ledgerwood J; Graham BS; Bennett H; Pajon R; Knightly C; Leav B; Deng W; Zhou H; Han S; Ivarsson M; Miller J; Zaks T; N Engl J Med; 2021 Feb; 384(5):403-416. PubMed ID: 33378609 [TBL] [Abstract][Full Text] [Related]